Medical Devices

Sempresto just cleared a key FDA hurdle for its phone-mounted auto-injector. But can attaching life-saving drugs to consumer tech disrupt the allergy market?

A new Southern California distribution deal for an FDA-cleared nerve ablation system could revolutionize treatment for trigeminal neuralgia, but risks remain.

NanoTess co-founders Megan Leslie and Julian Mulia win Canada's Top 40 Under 40 for a catalytic technology that addresses a massive healthcare crisis.

A breakthrough liquid nitrogen ablation device promises to revolutionize cardiac care, but its maker faces a brutal race against dwindling capital.

As specialty drugs strain Canada's healthcare system, a new partnership between Swisslog Healthcare and PharmaSystems aims to deliver advanced cold storage.

Foot Levelers’ new patented Nexi pillow isn't just a product; it's a strategic move to medicalize sleep, using AI and 3D scans to fight modern ills like 'tech neck'.

Following a $26M funding round, Epitel adds a proven commercial leader to its board, signaling a major push to dominate the remote neurology market.

Hyperfine has completed a pivotal study for its portable Swoop MRI. Adding contrast could revolutionize point-of-care diagnostics and unlock major market growth.

Neurodiagnostic giant Natus Medical is localizing production in China, a strategic pivot forced by policy shifts. This move is a blueprint for MedTech survival.

ScoliCare's new Durham clinic taps into a growing demand for non-surgical scoliosis care, challenging traditional treatment models with its tech-driven approach.

New research shows a contactless device can predict worsening asthma by listening for coughs, heralding a new era of proactive, data-driven healthcare.

As AdaptHealth hits the investor circuit, it faces tough questions on profitability, strategy shifts, and recent setbacks. Can leadership reassure the market?

With FDA approval for its RefluxStop® device, Implantica challenges the GERD treatment status quo, promising better outcomes without debilitating side effects.

Glucotrack secures $11.5M to fund a breakthrough diabetes monitor, but a look beneath the surface reveals a high-stakes gamble on AI and shareholder value.

As weight-loss drugs reshape bodies, Aesthetic Management Partners' deal for ATTIVA's subdermal tech signals a pivotal shift in the aesthetic device market.

From a record-breaking telesurgery spanning 13,600 miles to a life-saving operation on a 45-day-old infant, SS Innovations is rapidly democratizing advanced surgery.

A new partnership brings a European whitening technology to the U.S., promising a fast, pain-free smile boost integrated into routine dental cleanings.

Miami's DermaSensor lands $5M and four major US partnerships, setting the stage to rapidly scale its FDA-cleared AI skin cancer detection device nationwide.

With a unique EU certification, this UK firm's dissolvable beads deliver targeted antibiotic combinations, promising to slash revision surgeries and redefine care.

Despite a new 12.5% U.S. tariff, a bold analysis argues the Dominican Republic remains a top MedTech hub by focusing on total cost and supply chain resilience.